期刊文献+

原发性高血压患者血压变异性和血清高敏C反应蛋白及基质金属蛋白酶-9关系的研究 被引量:6

Relationship between blood pressure variability and serum high sensitive C-reactive protein and matrix metalloproteinase-9 in patients with essential hypertension
下载PDF
导出
摘要 目的研究原发性高血压(EH)患者血压变异性(BPV)与高敏C反应蛋白(hs-CRP)、基质金属蛋白酶-9(MMP-9)之间的关系。方法收集符合纳入标准的患者资料,分为高血压组(n=117例)和正常血压对照组(n=32例)。对入选的117例EH患者行24 h动态血压监测(ABPM),根据24 h收缩压变异性(24hSBPV)第50百分位数(P50)将其分为高BPV组(57例)和低BPV(60例)组。所有患者均采用胶乳比浊法测定hs-CRP,ELISA法测定MMP-9,比较各组hs-CRP和MMP-9水平。结果 EH组24 h SBPV高于对照组(P<0.01),hs-CRP和MMP-9较血压正常组也显著升高(P<0.01)。EH组中,高BPV组患者hs-CRP和MMP-9显著升高(P<0.01)。24 h SBPV与年龄、高血压病程、LDL-C、hs-CRP及MMP-9呈正相关;多元线性回归显示,hs-CRP、MMP-9、LDL-C进入回归方程。结论 EH患者BPV可能与hs-CRP及MMP-9相关。 Objective To study the relationship between blood pressure variability(BPV) and serum high sensitive C-reactive protein(hs-CRP) and matrix metalloproteinase-9(MMP-9) in patients with essential hypertension.Methods A total of 149 patients were included in the study.The participants were divided into two groups: those with hypertension(n=117) and those without hypertension(n=32).According to the results of 24 h ambulatory blood pressure monitoring for the selected 117 cases with essential hypertension,the patients with hypertension were divided into low and high variability groups according to the 50 th percentile of 24 h SBPV.Hs-CRP was measured with turbidimetry and MMP-9 with enzyme linked immunosorbent assay(ELISA) in the total patients.Results The patients with essential hypertension had significantly higher 24 h SBPV(P0.01) than those without hypertension.Serum hs-CRP and MMP-9 also were significantly higher in the patients with hypertension than those without hypertension(P0.01).Compared with the patients with lower BPV,the serum hs-CRP and MMP-9 increased significantly in the patients with higher BPV(P0.01).Pearson relation analysis showed that 24 h SBPV level had significant positive correlation with age,course of disease,LDL-C,hs-CRP and MMP-9 in patients with hypertension.Multivariate regression analysis showed that the LDL-C,hs-CRP,MMP-9 were predictors of 24 hSBPV levels.Conclusion The BPV is related to hs-CRP and MMP-9 in patients with essential hypertension.
出处 《中国临床保健杂志》 CAS 2013年第1期7-10,共4页 Chinese Journal of Clinical Healthcare
关键词 高血压 血压测定 C反应蛋白质 基质金属蛋白酶9 Hypertension Blood pressure determination C-reactive protein Matrix metalloproteinase9
  • 相关文献

参考文献12

  • 1Rothwell PM,Howard SC,Dolan E. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke[J].Lancet Neuro1,2010,(05):469-480.
  • 2Blanco F,Gil P,Arco CD. Association of clinic and ambulatory blood pressure with vascular damage in the elderly:the EPICARDIAN study[J].Blood Pressure Monitoring,2006,(06):329-335.doi:10.1097/01.mbp.0000218010.11323.b3.
  • 3Kozan O,Buyukozturk K,Ilerigelen B. The impact of plasma high-sensitivity C-reactive protein levels on cardiovascular risk stratification of hypertensive patients:results of the ICEBERG study[J].Journal of Clinical Hypertension(Greenwich),2007,(07):500-505.
  • 4Yasmin,McEniery CM,Wallace S. Matrix metalloproteinase-9(MMP-9),MMP-2,and serum elastase activity are associated with systolic hypertension and arterial stiffness[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2005,(02):372.
  • 5Gasanov AG,Bershova TV. The role of changes of matrix metalloproteinase in cardiovascular diseases[J].Russian Journal of Bioorganic Chemistry(Bioorganicheskaya Khimiya),2009,(02):155-168.
  • 6Berk BC,Fujiwara K,Lehoux S. ECM remodeling in hypertensive heart disease[J].Journal of Clinical Investigation,2007,(03):568-575.
  • 7Parati G,Pomidossi G,Albini F. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension[J].Hypertension,1987,(01):93-98.
  • 8Dahlof B,Sever PS,Poulter NR. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowing Arm(ASCOT-BPLA):a multicentre randomised controlled trial[J].The Lancet,2005,(9489):895-906.
  • 9Kato T,Kikuya M,Ohkubo T. Factors associated with day-by-day variability of self-measured blood pressure at home:the Ohasama study[J].American Journal of Hypertension,2010,(09):980-986.
  • 10Veerabhadrappa P,Diaz KM,Feairheller DL. Enhanced blood pressure variability in a high cardiovascular risk group of African Americans:FIT4Life Study[J].J Am Soc Hypertens,2010,(04):187-195.

同被引文献86

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部